In vitro anti-tumour effect of 1,10-phenanthroline-5,6-dione (phendione), [Cu(phendione)3](ClO4)2·4H2 O and [Ag(phendione)2]ClO4 using human epithelial cell lines

Chemico-Biological Interactions

Volumn 164, Issue 1-2, 2006, Pages 115-125

  Deegan, Carol ^a   Coyle, Barry ^a,b   McCann, Malachy ^a,b   Devereux, Michael ^a   Egan, Denise A ^a  

^a DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

1,10 Phenanthroline 5,6 dione; Anti cancer potential; DNA inhibition; Transitional metal complexes

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CUPRIC ION; PHENANTHROLINE DERIVATIVE; SILVER;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL VIABILITY; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; IC 50;

ANTINEOPLASTIC AGENTS; CELL LINE; CISPLATIN; COPPER; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; HUMANS; INHIBITORY CONCENTRATION 50; MUTAGENICITY TESTS; ORGANOMETALLIC COMPOUNDS; PERCHLORIC ACID; PHENANTHROLINES; SILVER COMPOUNDS;

EID: 33750824308     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2006.08.025     Document Type: Article

References (42)

1. Fricker P.S. Metal compounds in cancer therapy. The Role of Metals in Cancer Therapy (1994), Chapman and Hall, London pp. 10-15
2. Heffeter P., Jakupec M.A., Korner W., Wild S., von Keyserlingk N., Elbing L., Zorbas H., Korynerska A., Knasmuller S., and Sutterluty H. Anti-cancer activity of the lanthanium compound [tris-(1,10-phenanthroline)lanthanium(III) trithiocyanate] (KP772; FFG24). Biochem. Pharm. 71 (2006) 426-440
3. Zhang C.X., and Lippard S.J. New metal-complexes as potential therapeutics. Curr. Opin. Chem. Biol. 7 (2003) 481-489
4. Marzano C., Trevisan A., Giovagnini L., and Fregonal D. Synthesis of a new platinum(II) complex: anti-cancer activity and nephrotoxicity in vitro. Toxicol. In Vitro 16 (2002) 413-419
5. Fuertes M.A., Alonso C., and Perez J.M. Biochemical modulation of cisplatin mechanisms of action: enhancement of anti-tumour activity and circumvention of drug resistance. Chem. Rev. 103 (2003) 645-662
6. Farrell N. Biomedical uses and applications of inorganic chemistry: an overview. Coord. Chem. Rev. 232 (2002) 1-4
7. Wong E., and Giandomenico C.M. Current status of platinum-based anti-cancer drugs. Chem. Rev. 99 (1999) 2451-2466
8. Butler H.M., Hurse A., Thursky E., and Shulman A. Bactericidal action of selected phenanthroline chelates and related compounds. Aust. J. Exp. Biol. Med. Sci. 47 (1969) 541-552
9. MacLeod R.A. The toxicity of o-phenanthroline for lactic acid bacteria. J. Biol. Chem. 197 (1952) 751-761
10. Dwyer F.P., Reid I.K., Shulman A., Laycock G.M., and Dixon S. The biological actions of 1,10-phenanthroline and 2,2′-bipyridine hydrochlorides, quaternary salts and metal chelates and related compounds. Bacteriostatic action on selected gram-positive, gram-negative and acid-fast bacteria. Aust. J. Exp. Biol. Med. Sci. 47 (1969) 203-218
11. McCann M., Geraghty M., Devereux M., O'Shea D., Mason J., and O'Sullivan L. Insights into the mode of action of the anti-Candida activity of 1,10-phenanthroline and its metal chelates. Metal-Based Drugs 7 (2000) 185-193
12. Coyle B., McCann M., Kavanagh K., Devereux M., and Geraghty M. Mode of antifungal activity of 1,10-phenanthroline and its Cu(II), Mn(II) and Ag(I) complexes. Biometals 16 (2003) 321-329
13. Samuni A., Chevion M., and Czapski G. Unusual copper-induced sensitisation of the biological damage due to superoxide radicals. J. Biol. Chem. 256 (1981) 12632-12635
14. Wijker C.A., and Lafleur M.V. The presence of traces of iron and copper ions during γ-irradiation does not result in clear mutational hot spots in the lac1 gene. Mutat. Res. 429 (1999) 27-35
15. Linder M.C. Copper and genomic stability in mammals. Mutat. Res. 475 (2001) 141-152
16. Tsang S.Y., Tam S.C., Bremner L., and Burkitt M.J. Copper-1,10-phenanthroline induces internucleosomal DNA fragmentation in HepG2 cells, resulting from direct oxidation by the hydroxyl radical. Biochem. J. 317 (1996) 13-16
17. Zhou H., Lui Y., Zhen C., Gong J., Liang Y., Wang C., and Zou G. Microcalorimetric studies of the synergistic effects of copper-1,10-phenanthroline combined with hyperthermia on a liver hepatoma cell line Bel-7402. Thermochim. Acta 397 (2002) 87-95
18. Verhaegh G.W., Richard M.J., and Hainaut P. Regulation of p53 by metal ions and by antioxidants: dithiocarbamate down regulates p53 DNA-binding activity by increasing the intracellular levels of copper. Mol. Cell. Biol. 17 (1997) 5699-5706
19. Goss C.A., and Abruna H.D. Spectral, electrochemical and electrocatalytic properties of 1,10-phenanthroline-5,6-dione complexes of transition metals. Inorg. Chem. 24 (1985) 4263-4267
20. Wu Q., Maskus M., Pariente F., Tobalina F., Fernandez V.M., Lorenzo E., and Abruna H.D. Electrocatalytic oxidation of NADH at glassy carbon electrodes modified with transition metal complexes containing 1,10-phenanthroline-5,6-dione ligands. Anal. Chem. 68 (1996) 3688-3696
21. + regeneration. Chem. Eur. J. 3 (1997) 79-88
22. Yokoyama K., Asakura T., Nakamura N., and Ohno H. Chemical modification of cytochrome c by a ruthenium complex containing phenanthroline quinine. Inorg. Chem. Commun. 9 (2006) 281-283
23. Ghosh S., Barve A.C., Kumbhar A.A., Kumbhar A.S., Puranik V.G., Datar P.A., Sonawane U.B., and Joshi R.R. Synthesis, characterisation, X-ray structure and DNA photocleavage by cis-dichloro bis(diimine) Co(III) complexes. J. Inorg. Biochem. 100 (2006) 331-343
24. Yamada M., Tanaka Y., Yoshimoto Y., Kurodo S., and Shimao I. Synthesis and properties of diamino-substituted dipyrido[3,2-a: 2′,3′-c]phenazine. Bull. Chem. Soc. Jpn. 65 (1992) 1006-1011
25. Lui H., Du M., Ling X., Bu X.H., and Zhang R.H. Synthesis and chemical structure of the copper(II) complex with tris-(1,10-phenanthroline-5,6-dione). Chin. J. Struct. Chem. (Jiegou Huaxue) 19 (2000) 431-497
26. Coyle B., Kinsella P., McCann M., Devereux M., O'Connor R., Cylnes M., and Kavanagh K. Induction of apoptosis in yeast and mammalian cells by exposure to 1,10-phenanthroline metal complexes. Toxicol. In Vitro 18 (2004) 63-70
27. Mosmann T. Rapid colorimetric assay for cellular growth and survival: applications to proliferation and cytotoxicity assays. J. Immunol. 65 (1983) 55-63
28. Portsmann T., Ternyck T., and Aveameas S. Quantitation of 5-bromo-2-deoxyuridine incorporation into an enzyme immunoassay for the assessment of the lymphoid proliferative response. J. Immunol. Meth. 82 (1985) 169-179
29. Lorcozio A., and Long B.H. Biochemical characterisation of elasamicin and other coumarin-related anti-tumour agents as potent inhibitors of human topoisomerase II. Eur. J. Cancer 29A (1993) 1985-1991
30. Moran D.M., and Ames B.N. Revised methods for the Salmonella mutagenicity tests. Mutat. Res. 113 (1983) 173-215
31. Randford J.D., Sadler P.J., and Tocher D.A. Cytotoxicity and antiviral activity of transition-metal salicylato complexes and crystal structure of bis(diisopropylsalicylato)(1,10-phenanthroline) copper(I). Dalton Trans. (1993) 3393-3399
32. Coyle B., Kinsella P., McCann M., Devereux M., O'Connor R., Clynes M., and Kavanagh K. Induction of apoptosis in yeast and mammalian cells by exposure to 1,10-phenanthroline metal complexes. Toxicol. In Vitro 18 (2004) 63-70
33. 2 = malonic acid) using human cancer cells, Cancer Lett. (2006) (manuscript number: CL-1349-05).
34. 2 = cis-5-norbornene-endo-2,3-dicarboxylic acid; bipy = 2,2′-bipyridine; phen = 1,10-phenanthroline). Polyhedron 18 (1999) 2931-2939
35. Saha D.K., Sandbhor U., Shirisha K., Padhye S., Deobagkar D., Ansond C.E., and Powell A.K. A novel mixed-ligand antimycobacterial dimeric copper complex of ciprofloxacin and phenanthroline. Bioorg. Med. Chem. Lett. 14 (2004) 3027-3032
36. Zoroddu M.A., Zanetti S., Pogni R., and Basosi R. An electron spin resonance study and antimicrobial activity of copper(II) phenanthroline complexes. J. Inorg. Biochem. 63 (1996) 291-300
37. Ali B.H., and Al Moundhri M.S. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food Chem. Toxicol. 44 (2006) 1173-1183
38. Igdaloff D., Santi D.V., Eckert T.S., and Bruice T.C. Effects of 1,7- and 1,10-phenanthroline-dione on tissue culture cells. Biochem. Pharm. 32 (1983) 172-174
39. Hidalago E., and Dominguez C. Study of cytotoxic mechanisms of silver nitrate in human dermal fibroblasts. Toxicol. Lett. 98 (1997) 169-179
40. Waring M.J. Variations of the supercoils in closed circular DNA by binding of antibiotics and drugs: evidence for molecular models involving intercalation. J. Mol. Biol. 54 (1970) 247-279
41. Dougherty G. The unwinding of circular DNA by intercalating agents as determined by gel electrophoresis. Biosci. Rep. 3 (1983) 453-460
42. Cross H.J., Tilby M., Chipman J.K., Ferry D.R., and Gescher A. Effect of quercetin on the genotoxic potential of cisplatin. Int. J. Cancer 3 (1996) 404-408